I don’t know if Todd understood my Question, but I intended to ask if they could be sold off in order to acquire funds. I don’t see how all these pieces fit. Most OTC biotechs are one-trick ponies. IMO, Generex has too many ponies and they don’t all pull together. I hope that’s what Todd addressed, but I’m not sure.